Chapter One — 1.1 Background to the Study

In recent years, Health Insurance Enrollment has emerged as a critical factor shaping disease prevalence across organizations operating in and around Selected Family-Owned Businesses in Nigeria. As institutions grapple with the pressures of globalization, regulatory reform, and shifting stakeholder expectations, understanding how health insurance enrollment relates to disease prevalence has become an important area of both scholarly and practical concern.

Selected Family-Owned Businesses in Nigeria presents a useful setting for examining this relationship precisely because the conditions there — structural, regulatory, and behavioural — differ from those typically assumed in the broader literature, most of which draws on evidence from more developed economies.

1.2 Statement of the Problem

Despite a growing body of literature on health insurance enrollment, there remains limited consensus on the precise nature of its relationship with disease prevalence, particularly within Selected Family-Owned Businesses in Nigeria. Many organizations continue to make decisions about health insurance enrollment without a clear, evidence-based understanding of how those decisions ultimately affect disease prevalence. This gap between practice and empirical understanding is the central problem this study seeks to address.

1.3 Objectives of the Study

1. To examine the effect of Health Insurance Enrollment on disease prevalence in Selected Family-Owned Businesses in Nigeria.
2. To assess the extent to which health insurance enrollment influences disease prevalence within the study area.
3. To identify the challenges associated with health insurance enrollment in relation to disease prevalence.
4. To recommend strategies for optimizing health insurance enrollment in order to improve disease prevalence.

1.4 Research Questions

1. What is the effect of health insurance enrollment on disease prevalence in Selected Family-Owned Businesses in Nigeria?
2. To what extent does health insurance enrollment influence disease prevalence within the study area?
3. What challenges are associated with health insurance enrollment in relation to disease prevalence?
4. What strategies can be adopted to optimize health insurance enrollment in order to improve disease prevalence?

1.5 Significance of the Study

This study is significant to a range of stakeholders. For policymakers and regulators, the findings offer evidence to guide the design of frameworks that support healthier outcomes around disease prevalence. For managers and practitioners within Selected Family-Owned Businesses in Nigeria, the study provides practical insight into how health insurance enrollment can be better managed. Finally, it contributes to the academic literature on public health by extending existing knowledge into a specific empirical context, and offers a reference point for future researchers.

1.6 Scope of the Study

The study is limited to an examination of Health Insurance Enrollment and its relationship with disease prevalence within the context of Selected Family-Owned Businesses in Nigeria. It reflects a BSc-level scope of analysis and relies on data and perspectives available within that scope; generalizing the findings beyond this specific context should therefore be done with appropriate caution.